Amalgamated Bank’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Amalgamated Bank’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,176	Closed	-$41K	–	3186
2024 Q1	$41K	Sell	1,176 -3,074	-72%	-$112K	﹤0.01%	1912
2023 Q4	$162K	Sell	4,250 -350	-8%	-$7.5K	﹤0.01%	1859
2023 Q3	$84K	Hold	4,600	–	–	﹤0.01%	2060
2023 Q2	$119K	Sell	4,600 -4	-0.1%	-$93	﹤0.01%	2004
2023 Q1	$87K	Sell	4,604 -848	-16%	-$19.7K	﹤0.01%	2115
2022 Q4	$134K	Buy	5,452 +835	+18%	+$24.5K	﹤0.01%	2016
2022 Q3	$83K	Buy	4,617 +71	+2%	+$1.28K	﹤0.01%	2244
2022 Q2	$52K	Buy	4,546 +1	+0%	+$15	﹤0.01%	2465
2022 Q1	$101K	Sell	4,545 -383	-8%	-$9.78K	﹤0.01%	2192
2021 Q4	$215K	Buy	+4,928	New	+$197K	﹤0.01%	1954

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Amalgamated Bank's INBX Position: Q2 2024 in Review

Amalgamated Bank sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 1,176 shares — an estimated $41K sold.

Amalgamated Bank first reported a position in INBX in Q4 2021 and held it in 10 quarters. The position peaked at $215K in Q4 2021. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Amalgamated Bank reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Amalgamated Bank sold 1,176 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $41K.
Amalgamated Bank first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
Amalgamated Bank's Inhibrx, Inc. Common Stock position peaked at $215K in Q4 2021.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.